These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8269604

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.
    Teicher BA, Wong JS, Takeuchi H, Gravelin LM, Ara G, Buxton D.
    Cancer Chemother Pharmacol; 1998; 42(1):24-30. PubMed ID: 9619754
    [Abstract] [Full Text] [Related]

  • 23. Cyclocreatine in cancer chemotherapy.
    Teicher BA, Menon K, Northey D, Liu J, Kufe DW, Kaddurah-Daouk R.
    Cancer Chemother Pharmacol; 1995; 35(5):411-6. PubMed ID: 7850923
    [Abstract] [Full Text] [Related]

  • 24. The angiogenesis inhibitor beta-cyclodextrin tetradecasulfate inhibits ecto-protein kinase activity.
    Skubitz KM, Ehresmann DD.
    Cell Mol Biol; 1992 Sep; 38(6):543-60. PubMed ID: 1284648
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET, Kelley M, Rockwell S.
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [Abstract] [Full Text] [Related]

  • 30. Antitumor activity of cryptophycins: effect of infusion time and combination studies.
    Menon K, Alvarez E, Forler P, Phares V, Amsrud T, Shih C, Al-Awar R, Teicher BA.
    Cancer Chemother Pharmacol; 2000 Jan; 46(2):142-9. PubMed ID: 10972484
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour.
    Miller BE, Miller FR, Machemer T, Heppner GH.
    Br J Cancer; 1993 Jul; 68(1):18-25. PubMed ID: 8318410
    [Abstract] [Full Text] [Related]

  • 36. Affinity of fibroblast growth factors for beta-cyclodextrin tetradecasulfate.
    Yuen SN, Folkman J, Weisz PB, Joullie MM, Ewing WR.
    Anal Biochem; 1990 Feb 15; 185(1):108-11. PubMed ID: 2344037
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Synergistic anti-tumor activity of a novel immunomodulator, BCH-1393, in combination with cyclophosphamide.
    Kadhim S, Penney C, Lagraoui M, Heibein J, Attardo G, Zacharie B, Connolly T, Gagnon L.
    Int J Immunopharmacol; 2000 Sep 15; 22(9):659-71. PubMed ID: 10884587
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro.
    Rosbe KW, Brann TW, Holden SA, Teicher BA, Frei E.
    Cancer Chemother Pharmacol; 1989 Sep 15; 25(1):32-6. PubMed ID: 2590999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.